|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.828
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.827
|
Rat |
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.796
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.733
|
Human |
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.656
|
Rat |
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.653
|
Mouse |
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.652
|
Rat |
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.644
|
Rat |
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.637
|
Rat |
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.634
|
Rat |
|
membrane organization
|
GO:0061024 |
245 |
0.628
|
Human |
|
muscle cell development
|
GO:0055001 |
133 |
0.600
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.597
|
Rat |
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.582
|
Rat |
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.569
|
Rat |
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.564
|
Rat |
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.548
|
Rat |
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.521
|
Rat |
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.512
|
Rat |
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.509
|
Rat |
|
hemostasis
|
GO:0007599 |
78 |
0.505
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.502
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.499
|
Rat |
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.481
|
Rat |
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.481
|
Rat |
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.474
|
Rat |
|
cell adhesion
|
GO:0007155 |
329 |
0.471
|
Mouse |
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.457
|
Rat |
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.446
|
Mouse |
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.413
|
Rat |
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.410
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.408
|
Mouse |
|
digestive system development
|
GO:0055123 |
200 |
0.401
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.396
|
Rat |
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.396
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.386
|
Rat |
|
striated muscle cell development
|
GO:0055002 |
125 |
0.376
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.371
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.368
|
Rat |
|
endomembrane system organization
|
GO:0010256 |
147 |
0.366
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.366
|
Human Mouse |
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.341
|
Rat |
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.340
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.337
|
Rat |
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.334
|
Rat |
|
epithelial cell development
|
GO:0002064 |
159 |
0.319
|
Mouse |
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.312
|
Rat |
|
organelle assembly
|
GO:0070925 |
177 |
0.311
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.302
|
Rat |
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.297
|
Rat |
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.295
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.294
|
Rat |
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.289
|
Rat |
|
cellular response to salt stress
|
GO:0071472 |
1 |
0.282
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.281
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.276
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.273
|
Rat |
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.273
|
Human |
|
cell junction organization
|
GO:0034330 |
77 |
0.266
|
Human |
|
kidney development
|
GO:0001822 |
213 |
0.246
|
Mouse |
|
intracellular protein transport
|
GO:0006886 |
204 |
0.245
|
Human |
|
digestive tract development
|
GO:0048565 |
190 |
0.244
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.244
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.243
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.242
|
Human Mouse |
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.239
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.239
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.238
|
|
|
wound healing
|
GO:0042060 |
157 |
0.236
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.229
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.225
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.223
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.220
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.220
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.218
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.218
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.216
|
Rat |
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.213
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.208
|
Rat |
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.207
|
|
|
cation transport
|
GO:0006812 |
399 |
0.204
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.204
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.203
|
Rat |
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.202
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.198
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.197
|
Rat |
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.194
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.193
|
Mouse |
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.192
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.186
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.186
|
Human Mouse |
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.185
|
Rat |
|
atp catabolic process
|
GO:0006200 |
55 |
0.182
|
Rat |
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.176
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.176
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.176
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.176
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.175
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.173
|
Human |
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.173
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.171
|
Rat |
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.171
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.167
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.159
|
Rat |
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.159
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.158
|
Rat |
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.156
|
|
|
gland development
|
GO:0048732 |
330 |
0.156
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.154
|
Human |
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.153
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.152
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.145
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.142
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.140
|
Human |
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.140
|
Mouse |
|
cation homeostasis
|
GO:0055080 |
212 |
0.140
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.140
|
Rat |
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.140
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.137
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.136
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.135
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.134
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.134
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.132
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.131
|
Rat |
|
response to peptide
|
GO:1901652 |
136 |
0.130
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.129
|
Human |
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.127
|
Human |
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.127
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.126
|
Human Mouse |
|
endocytosis
|
GO:0006897 |
168 |
0.126
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.125
|
Rat |
|
regulation of endocytic recycling
|
GO:2001135 |
3 |
0.125
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.121
|
Mouse |
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.121
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.118
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.118
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.118
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.117
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.116
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.115
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.113
|
Human |
|
cellular response to hepatocyte growth factor stimulus
|
GO:0035729 |
2 |
0.112
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.112
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.112
|
Human |
|
maintenance of location
|
GO:0051235 |
89 |
0.111
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.111
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.109
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.109
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.106
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.106
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.105
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.104
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.104
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.103
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.101
|
Fly |
|
jnk cascade
|
GO:0007254 |
72 |
0.100
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.099
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.099
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.099
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.098
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.098
|
|
|
cell growth
|
GO:0016049 |
130 |
0.097
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.097
|
Human |
|
response to amino acid
|
GO:0043200 |
37 |
0.097
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.097
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.096
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.095
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.095
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.094
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.093
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.093
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.092
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.090
|
Rat |
|
response to oxygen levels
|
GO:0070482 |
62 |
0.090
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.089
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.089
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.088
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.088
|
Mouse |
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.088
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.088
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.088
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.088
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.087
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.087
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.085
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.084
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.084
|
Human |
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.084
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.083
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.080
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.079
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.079
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.078
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.077
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.077
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.077
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.077
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.076
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.076
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.076
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.074
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.074
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.073
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.073
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.071
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.071
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.070
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.070
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.070
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.069
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.069
|
Human Mouse |
|
cell chemotaxis
|
GO:0060326 |
81 |
0.069
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.069
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.068
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.068
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.067
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.067
|
|
|
regulation of lamellipodium morphogenesis
|
GO:2000392 |
1 |
0.067
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.067
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.067
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.067
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.065
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.065
|
|
|
renal system development
|
GO:0072001 |
225 |
0.065
|
Mouse |
|
regulation of ion transport
|
GO:0043269 |
215 |
0.065
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.064
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.064
|
Mouse |
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.064
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.063
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.063
|
|
|
protein processing
|
GO:0016485 |
163 |
0.063
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.062
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.062
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.062
|
Mouse |
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.062
|
|
|
positive regulation of endocytic recycling
|
GO:2001137 |
2 |
0.061
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.061
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.060
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.060
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.059
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.059
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.059
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.059
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.059
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.059
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.058
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.058
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.058
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.058
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.058
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.057
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.057
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.057
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.057
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.056
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.056
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.056
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.055
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.055
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.055
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.054
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.054
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.054
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.054
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.053
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.053
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.053
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.053
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.053
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.052
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.052
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.052
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.051
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.051
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.051
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.051
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.051
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.051
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.051
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.050
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.050
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.050
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.050
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.050
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.049
|
Mouse |
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.049
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.049
|
Rat |
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.049
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.049
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.048
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.048
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.048
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.048
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.048
|
Rat |
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.047
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.047
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.047
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.047
|
|
|
cell substrate adherens junction assembly
|
GO:0007045 |
19 |
0.047
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.047
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.046
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.046
|
Rat |
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.046
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.046
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.046
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.045
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.045
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.045
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.045
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.045
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.045
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.045
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.044
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.044
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.044
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.044
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.044
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.044
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.043
|
Human |
|
apical junction assembly
|
GO:0043297 |
15 |
0.043
|
Human |
|
regulation of cell activation
|
GO:0050865 |
289 |
0.043
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.043
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.043
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.042
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.042
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.042
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.042
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.042
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.041
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.041
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.041
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.041
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.041
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.041
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.041
|
|
|
action potential
|
GO:0001508 |
78 |
0.041
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.041
|
Mouse |
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.040
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.040
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.040
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.040
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.039
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.039
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.039
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.039
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.039
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.038
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.038
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.038
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.038
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.038
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.038
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.038
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.037
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.037
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.037
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.037
|
|
|
regulation of blood vessel endothelial cell migration
|
GO:0043535 |
12 |
0.037
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.037
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.036
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.036
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.036
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.036
|
Rat |
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.036
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.035
|
Mouse |
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.035
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.035
|
Mouse |
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.035
|
|
|
lamellipodium morphogenesis
|
GO:0072673 |
5 |
0.035
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.035
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.035
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.034
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.034
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.034
|
|
|
heart process
|
GO:0003015 |
94 |
0.034
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.034
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.034
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.034
|
|
|
protein targeting to plasma membrane
|
GO:0072661 |
7 |
0.034
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.034
|
|
|
cell aging
|
GO:0007569 |
35 |
0.034
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.034
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.034
|
|
|
coagulation
|
GO:0050817 |
78 |
0.033
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.033
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.033
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.033
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.033
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.033
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.033
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.033
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.033
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.032
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.032
|
Human |
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.032
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.032
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.032
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.032
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.032
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.032
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.032
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.031
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.031
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.031
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.031
|
Mouse |
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.031
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.031
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.031
|
|
|
response to hepatocyte growth factor
|
GO:0035728 |
2 |
0.031
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.031
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.031
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.031
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.030
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.030
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.030
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.030
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.030
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.030
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.030
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.030
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.030
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.030
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.029
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.029
|
|
|
protein targeting to membrane
|
GO:0006612 |
20 |
0.029
|
Human |
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.029
|
Mouse |
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.029
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.029
|
|
|
plasma membrane long chain fatty acid transport
|
GO:0015911 |
1 |
0.029
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.029
|
|
|
anion transport
|
GO:0006820 |
177 |
0.029
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.029
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.029
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.029
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.029
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.029
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.029
|
|
|
cellularization
|
GO:0007349 |
1 |
0.028
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.028
|
|
|
cognition
|
GO:0050890 |
149 |
0.028
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.028
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.028
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.028
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.028
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.028
|
Mouse |
|
epithelium migration
|
GO:0090132 |
63 |
0.028
|
|
|
negative regulation of release of cytochrome c from mitochondria
|
GO:0090201 |
6 |
0.028
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.028
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.028
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.027
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.027
|
|
|
lung development
|
GO:0030324 |
164 |
0.027
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.027
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.027
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.027
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.027
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.027
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.027
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.027
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.027
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.027
|
Human |
|
female gamete generation
|
GO:0007292 |
74 |
0.027
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.026
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.026
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.026
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.026
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.026
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.026
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.026
|
|
|
myelination
|
GO:0042552 |
74 |
0.026
|
|
|
regulation of stress fiber assembly
|
GO:0051492 |
15 |
0.026
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.026
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.026
|
|
|
cell division
|
GO:0051301 |
120 |
0.026
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.026
|
|